Announcement on Voluntary Disclosure of the Approval for Market Launch of Recombinant Human Thyrotropin β for Injection

About this update from Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class A

Announcement on Voluntary Disclosure of the Approval for Market Launch of Recombinant Human Thyrotropin β for Injection The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Suzhou Zelgen Biopharmaceuticals Co. Ltd. Class A